[go: up one dir, main page]

CN111897298A - Method and system for monitoring acoustic emission in preparation process of traditional Chinese medicine particles in fluidized bed - Google Patents

Method and system for monitoring acoustic emission in preparation process of traditional Chinese medicine particles in fluidized bed Download PDF

Info

Publication number
CN111897298A
CN111897298A CN202010734810.5A CN202010734810A CN111897298A CN 111897298 A CN111897298 A CN 111897298A CN 202010734810 A CN202010734810 A CN 202010734810A CN 111897298 A CN111897298 A CN 111897298A
Authority
CN
China
Prior art keywords
fluidized bed
principal component
control model
acoustic emission
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010734810.5A
Other languages
Chinese (zh)
Inventor
瞿海斌
赵洁
傅豪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University ZJU
Original Assignee
Zhejiang University ZJU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University ZJU filed Critical Zhejiang University ZJU
Priority to CN202010734810.5A priority Critical patent/CN111897298A/en
Publication of CN111897298A publication Critical patent/CN111897298A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G05CONTROLLING; REGULATING
    • G05BCONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B19/00Programme-control systems
    • G05B19/02Programme-control systems electric
    • G05B19/418Total factory control, i.e. centrally controlling a plurality of machines, e.g. direct or distributed numerical control [DNC], flexible manufacturing systems [FMS], integrated manufacturing systems [IMS] or computer integrated manufacturing [CIM]
    • G05B19/41885Total factory control, i.e. centrally controlling a plurality of machines, e.g. direct or distributed numerical control [DNC], flexible manufacturing systems [FMS], integrated manufacturing systems [IMS] or computer integrated manufacturing [CIM] characterised by modeling, simulation of the manufacturing system
    • GPHYSICS
    • G05CONTROLLING; REGULATING
    • G05BCONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B2219/00Program-control systems
    • G05B2219/30Nc systems
    • G05B2219/32Operator till task planning
    • G05B2219/32339Object oriented modeling, design, analysis, implementation, simulation language

Landscapes

  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • General Engineering & Computer Science (AREA)
  • Quality & Reliability (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Automation & Control Theory (AREA)
  • Glanulating (AREA)

Abstract

The invention discloses an acoustic emission monitoring system for preparing traditional Chinese medicine particles by a fluidized bed, which comprises an acoustic emission sensor arranged on the bed body of the fluidized bed and used for receiving acoustic signal data of the fluidized bed; the amplifier and the acquisition card are used for amplifying and acquiring acoustic signal data at fixed time intervals; a computer system comprising a data preprocessing program module and a multivariate statistical process monitoring program module.

Description

一种流化床中药颗粒制备过程声发射监控方法和系统Acoustic emission monitoring method and system for preparation process of traditional Chinese medicine granules in a fluidized bed

技术领域technical field

本发明涉及中药颗粒生产过程的在线监控技术领域,尤其涉及一种基于声发射技术的流化床制备中药颗粒的过程监控方法和系统。The invention relates to the technical field of on-line monitoring of the production process of traditional Chinese medicine granules, in particular to a process monitoring method and system for preparing traditional Chinese medicine granules in a fluidized bed based on acoustic emission technology.

背景技术Background technique

流化床喷雾制粒技术为集混合、制粒、干燥操作一步完成的新型制粒技术。与其他方法相比,具有工艺简单、操作时间短、劳动强度低等优点,在制药行业中,流化床一步制粒技术已在国内外广泛应用。Fluidized bed spray granulation technology is a new type of granulation technology that integrates mixing, granulation and drying operations in one step. Compared with other methods, it has the advantages of simple process, short operation time and low labor intensity. In the pharmaceutical industry, the fluidized bed one-step granulation technology has been widely used at home and abroad.

中药颗粒的质量一直是人们关注的焦点。制备过程的优劣是影响中药颗粒质量的重要因素,保证颗粒生产过程稳定的关键在于对制粒过程进行实时监测和控制,从而确保一致的生产流程最终得到高品质的产品。传统的工艺控制策略是在制粒过程中间隔取样,通过观察或离线分析样品调整工艺参数。离线的检测方式操作繁琐,检测具有滞后性,不能满足工业生产自动化的要求。过程监测技术可以对流化床制粒过程进行实时在线测量,使药品制粒环节可视化,对于加深制药过程的理解,控制药品的质量以及保证药品的一致性具有重要意义。The quality of traditional Chinese medicine granules has always been the focus of attention. The quality of the preparation process is an important factor affecting the quality of traditional Chinese medicine granules. The key to ensuring the stability of the granule production process is to monitor and control the granulation process in real time, so as to ensure a consistent production process and ultimately obtain high-quality products. The traditional process control strategy is to take samples at intervals during the granulation process and adjust the process parameters by observing or analyzing the samples offline. The offline detection method is cumbersome to operate, and the detection is hysteretic, which cannot meet the requirements of industrial production automation. Process monitoring technology can perform real-time online measurement of the fluidized bed granulation process and visualize the pharmaceutical granulation process, which is of great significance for deepening the understanding of the pharmaceutical process, controlling the quality of drugs and ensuring the consistency of drugs.

发明内容SUMMARY OF THE INVENTION

有鉴于现有技术的上述缺陷,本发明所要解决的技术问题是如何实时且安全环保地对流化床中药颗粒制备过程进行监控。In view of the above-mentioned defects of the prior art, the technical problem to be solved by the present invention is how to monitor the preparation process of the fluidized bed Chinese medicine granules in a real-time, safe and environment-friendly manner.

为实现上述目的,本发明在第一方面提供了一种流化床中药颗粒制备过程声发射监控方法,包括步骤:In order to achieve the above object, the present invention provides, in the first aspect, a method for monitoring acoustic emission during the preparation of fluidized bed Chinese medicine granules, comprising the steps of:

(1)通过设置于流化床床体的声发射传感器采集声信号数据;(1) Acoustic signal data is collected by an acoustic emission sensor arranged on the fluidized bed;

(2)将采集到的流化床在正常工作状态下的声信号数据作为校正集;通过快速傅里叶变换将校正集的声信号数据由时域信号转化为频域信号,并将频谱均分为N段,每段计算平均值,得到包含N个变量的分段平均频谱;采用数据对齐算法对频谱数据进行对齐处理;(2) Take the collected acoustic signal data of the fluidized bed under normal working conditions as a calibration set; convert the acoustic signal data of the calibration set from time domain signals to frequency domain signals through fast Fourier transform, and convert the spectral averages. It is divided into N segments, and the average value of each segment is calculated to obtain a segmented average spectrum containing N variables; the data alignment algorithm is used to align the spectrum data;

(3)建立包括主成分控制模型、Hotelling's T2控制模型和DModX控制模型的多变量统计过程监控模型;通过包含至少6个批次的正常工作状态下流化床的声信号数据的校正集对主成分控制模型、Hotelling's T2控制模型和DModX控制模型进行训练;(3) Establish a multivariate statistical process monitoring model including principal component control model, Hotelling's T2 control model and DModX control model; Ingredient control model, Hotelling's T2 control model and DModX control model for training;

(4)将训练所得的多变量统计过程监控模型用于对流化床中药颗粒的制备过程进行监控。(4) The multivariate statistical process monitoring model obtained by training is used to monitor the preparation process of TCM granules in the fluidized bed.

进一步地,步骤(1)中,声发射传感器被设置流化床的装料室的取样口高度处。Further, in step (1), the acoustic emission sensor is set at the height of the sampling port of the charging chamber of the fluidized bed.

进一步地,步骤(2)中,采用相关系数校正法对频谱数据进行对齐。Further, in step (2), a correlation coefficient correction method is used to align the spectral data.

进一步地,步骤(3)中,主成分控制模型的主成分得分轨迹计算公式为:Further, in step (3), the calculation formula of the principal component score trajectory of the principal component control model is:

Figure BDA0002604464010000021
Figure BDA0002604464010000021

式中,TNOC为NOC批次的得分矩阵,

Figure BDA0002604464010000022
为NOC批次的载荷矩阵,ENOC为残差矩阵;where T NOC is the score matrix of NOC batches,
Figure BDA0002604464010000022
is the loading matrix of the NOC batch, and E NOC is the residual matrix;

采用均值±3倍标准偏差为主成分控制模型的主成分控制图的控制限。Control limits for the principal components control chart of the principal component control model using the mean ± 3 standard deviations.

进一步地,步骤(3)中,Hotelling's T2控制模型的计算公式为:Further, in step (3), the calculation formula of Hotelling's T 2 control model is:

Figure BDA0002604464010000023
Figure BDA0002604464010000023

式中,ti是第i个主成分的得分,

Figure BDA0002604464010000024
为ti的方差,A表示主成分控制模型中主成分的数量;Hotelling's T2的控制限用用F分布来计算,公式为:where t i is the score of the i-th principal component,
Figure BDA0002604464010000024
is the variance of t i , A represents the number of principal components in the principal component control model; the control limit of Hotelling's T 2 is calculated by F distribution, and the formula is:

Figure BDA0002604464010000025
Figure BDA0002604464010000025

式中,K为校正集的批次数目,F为置信水平为1-α,自由度为(A,K-A)时F分布的临界值。In the formula, K is the number of batches of the calibration set, F is the critical value of the F distribution when the confidence level is 1-α and the degree of freedom is (A, K-A).

进一步地,步骤(3)中,DModX控制模型中任一批次的声信号数据在k时刻的DModX值计算公式为:Further, in step (3), the DModX value calculation formula of any batch of acoustic signal data in the DModX control model at time k is:

Figure BDA0002604464010000026
Figure BDA0002604464010000026

式中,en为观测值xn的残差向量,

Figure BDA0002604464010000027
为主成分控制模型中n时刻xn的预测值,K为光谱变量,A表示主成分控制模型中主成分的数量;In the formula, e n is the residual vector of the observation value x n ,
Figure BDA0002604464010000027
is the predicted value of x n at time n in the principal component control model, K is the spectral variable, and A represents the number of principal components in the principal component control model;

通过均值±3倍标准偏差确立DModX控制模型的控制限,公式为:The control limits of the DModX control model were established by the mean ± 3 times the standard deviation, and the formula was:

Figure BDA0002604464010000028
Figure BDA0002604464010000028

式中,

Figure BDA0002604464010000029
为校正集的平均值,SD为建立主成分控制模型中样本DModX统计量的标准偏差。In the formula,
Figure BDA0002604464010000029
is the mean of the calibration set, SD is the standard deviation of the sample DModX statistic in the establishment of the principal component control model.

本发明在第二方面提供了一种流化床制备中药颗粒的声发射监控系统,包括设置于流化床床体的声发射传感器,用于接收流化床的声信号数据;放大器和采集卡,用于放大和固定时间间隔采集声信号数据;计算机系统,计算机系统包括数据预处理程序模块和多变量统计过程监控程序模块,其中数据预处理程序模块通过快速傅里叶变换将声信号数据由时域信号转化为频域信号,并将频谱均分为N段,每段计算平均值,得到包含N个变量的分段平均频谱;采用数据对齐算法对频谱数据进行对齐处理;多变量统计过程监控程序模块包括主成分控制模块、Hotelling's T2控制模块和DModX控制模块。The present invention provides, in a second aspect, an acoustic emission monitoring system for preparing traditional Chinese medicine particles in a fluidized bed, comprising an acoustic emission sensor disposed on the fluidized bed body for receiving acoustic signal data of the fluidized bed; an amplifier and a collection card , used to amplify and collect acoustic signal data at fixed time intervals; the computer system includes a data preprocessing program module and a multivariate statistical process monitoring program module, wherein the data preprocessing program module converts the acoustic signal data from the The time domain signal is converted into a frequency domain signal, and the spectrum is divided into N segments, and the average value of each segment is calculated to obtain a segmented average spectrum containing N variables; the data alignment algorithm is used to align the spectrum data; multivariate statistical process The monitoring program modules include principal component control module, Hotelling's T 2 control module and DModX control module.

进一步地,主成分控制模块中的主成分得分轨迹计算公式为:Further, the calculation formula of the principal component score trajectory in the principal component control module is:

Figure BDA0002604464010000031
Figure BDA0002604464010000031

式中,TNOC为NOC批次的得分矩阵,

Figure BDA0002604464010000032
为NOC批次的载荷矩阵,ENOC为残差矩阵;where T NOC is the score matrix of NOC batches,
Figure BDA0002604464010000032
is the loading matrix of the NOC batch, and E NOC is the residual matrix;

采用均值±3倍标准偏差为主成分控制模型的主成分控制图的控制限。Control limits for the principal components control chart of the principal component control model using the mean ± 3 standard deviations.

进一步地,Hotelling's T2控制模块的计算公式为:Further, the calculation formula of Hotelling's T 2 control module is:

Figure BDA0002604464010000033
Figure BDA0002604464010000033

式中,ti是第i个主成分的得分,

Figure BDA0002604464010000034
为ti的方差,A表示主成分控制模型中主成分的数量;Hotelling's T2的控制限用用F分布来计算,公式为:where t i is the score of the i-th principal component,
Figure BDA0002604464010000034
is the variance of t i , A represents the number of principal components in the principal component control model; the control limit of Hotelling's T 2 is calculated by F distribution, and the formula is:

Figure BDA0002604464010000035
Figure BDA0002604464010000035

式中,K为校正集的批次数目,F为置信水平为1-α,自由度为(A,K-A)时F分布的临界值。In the formula, K is the number of batches of the calibration set, F is the critical value of the F distribution when the confidence level is 1-α and the degree of freedom is (A, K-A).

进一步地,DModX控制模块中任一批次的声信号数据在k时刻的DModX值计算公式为:Further, the calculation formula of the DModX value at time k of any batch of acoustic signal data in the DModX control module is:

Figure BDA0002604464010000036
Figure BDA0002604464010000036

式中,en为观测值xn的残差向量,

Figure BDA0002604464010000037
为主成分控制模型中n时刻xn的预测值,K为光谱变量,A表示主成分控制模型中主成分的数量;In the formula, e n is the residual vector of the observation value x n ,
Figure BDA0002604464010000037
is the predicted value of x n at time n in the principal component control model, K is the spectral variable, and A represents the number of principal components in the principal component control model;

通过均值±3倍标准偏差确立DModX控制模型的控制限,公式为:The control limits of the DModX control model were established by the mean ± 3 times the standard deviation, and the formula was:

Figure BDA0002604464010000038
Figure BDA0002604464010000038

式中,

Figure BDA0002604464010000039
校正集的平均值,SD为建立主成分控制模型中样本DModX统计量的标准偏差。In the formula,
Figure BDA0002604464010000039
The mean of the calibration set, SD is the standard deviation of the sample DModX statistic in the establishment of the principal component control model.

声发射检测技术安全环保,检测灵敏,信息丰富,非侵入的信号获取方式能保证流化床制粒过程中的流化状态不被破坏,且声发射信号采集速度迅速,由计算机对声发射采集的数据处理及统计分析过程可以在不到1min内完成,采用声发射在线监测流化床制粒过程可以满足工业生产上实时在线测量的要求,有利于及时地发现产品品质的变化,便于及时调控,维持产品质量的稳定。Acoustic emission detection technology is safe and environmentally friendly, sensitive in detection, rich in information, and the non-invasive signal acquisition method can ensure that the fluidized state in the process of fluidized bed granulation is not destroyed, and the acquisition speed of acoustic emission signals is fast. The process of data processing and statistical analysis can be completed in less than 1 minute. The use of acoustic emission to monitor the fluidized bed granulation process online can meet the requirements of real-time online measurement in industrial production, which is conducive to timely detection of product quality changes and timely regulation. , to maintain the stability of product quality.

以下将结合附图对本发明的构思、具体结构及产生的技术效果作进一步说明,以充分地了解本发明的目的、特征和效果。The concept, specific structure and technical effects of the present invention will be further described below in conjunction with the accompanying drawings, so as to fully understand the purpose, characteristics and effects of the present invention.

附图说明Description of drawings

图1是本发明的一个较佳实施例中的流化床中药颗粒制备过程声发射监控方法的流程图;Fig. 1 is the flow chart of the acoustic emission monitoring method of the fluidized bed Chinese medicine particle preparation process in a preferred embodiment of the present invention;

图2是本发明的一个较佳实施例中的流化床中药颗粒制备过程声发射监控系统的示意图;Fig. 2 is the schematic diagram of the acoustic emission monitoring system of the preparation process of fluidized bed Chinese medicine granules in a preferred embodiment of the present invention;

图3是本发明的一个较佳实施例中的声信号的不同采集时长的频谱图;3 is a spectrogram of different acquisition time lengths of acoustic signals in a preferred embodiment of the present invention;

图4是本发明的一个较佳实施例中的声信号的原始平均频谱图;Fig. 4 is the original average spectrogram of the acoustic signal in a preferred embodiment of the present invention;

图5是本发明的一个较佳实施例中的声信号的分段平均频谱;Fig. 5 is the piecewise average frequency spectrum of the acoustic signal in a preferred embodiment of the present invention;

图6是本发明的一个较佳实施例中的对齐处理前的过程数据图;6 is a process data diagram before alignment processing in a preferred embodiment of the present invention;

图7是本发明的一个较佳实施例中的对齐处理后的过程数据图.7 is a process data diagram after alignment processing in a preferred embodiment of the present invention.

具体实施方式Detailed ways

以下参考说明书附图介绍本发明的多个优选实施例,使其技术内容更加清楚和便于理解。本发明可以通过许多不同形式的实施例来得以体现,本发明的保护范围并非仅限于文中提到的实施例。The following describes several preferred embodiments of the present invention with reference to the accompanying drawings, so as to make its technical content clearer and easier to understand. The present invention can be embodied in many different forms of embodiments, and the protection scope of the present invention is not limited to the embodiments mentioned herein.

如图1、2所示,在根据本发明的换一个具体实施例中,1为流化床的滤袋,2为喷枪,3为取样口,4为声发射传感器,5为放大器,6为采集卡,7为计算机系统。在流化床装料室的取样口3高度布置声发射传感器4,同气流分布板的垂直距离为23.5cm。声信号被传感器4接收后转换为电信号,经放大器5放大后由DS5-8B全信息声发射信号分析仪转化为数字信号,最后通过配套的采集卡6和采集软件记录声信号数据。声发射信号的采样频率为3MHz,在流化床制粒过程中固定时间间隔采集声信号,直至制粒结束。As shown in Figures 1 and 2, in another specific embodiment according to the present invention, 1 is a filter bag of the fluidized bed, 2 is a spray gun, 3 is a sampling port, 4 is an acoustic emission sensor, 5 is an amplifier, and 6 is an The acquisition card, 7 is the computer system. The acoustic emission sensor 4 is arranged at the height of the sampling port 3 of the fluidized bed charging chamber, and the vertical distance from the gas distribution plate is 23.5 cm. The acoustic signal is received by the sensor 4 and converted into an electrical signal, amplified by the amplifier 5 and converted into a digital signal by the DS5-8B full-information acoustic emission signal analyzer, and finally the acoustic signal data is recorded through the matching acquisition card 6 and acquisition software. The sampling frequency of the acoustic emission signal is 3MHz, and the acoustic signal is collected at fixed time intervals during the fluidized bed granulation process until the end of the granulation.

收集不同批次流化床制备中药颗粒过程中的声发射信号,将采集的不同批次的数据按照一定比例划分为校正集和验证集。Acoustic emission signals during the preparation of traditional Chinese medicine granules in different batches of fluidized bed were collected, and the collected data of different batches were divided into calibration set and validation set according to a certain proportion.

鉴于预实验表明不同采集时长的频谱峰型相似,信号采集时长定为2s,如图3所示。In view of the fact that the pre-experiment shows that the spectral peak shapes of different acquisition durations are similar, the signal acquisition duration is set to 2s, as shown in Figure 3.

采集流化床制粒过程中的声发射信号,直至制粒结束。建模前将采集到的原始时域信号转化为频域信号,具体方案为将2s的时域信号均分为50段,每段时域信号作快速傅里叶变换(FFT)后得频谱,将50张频谱取平均,得2s声信号的平均频谱图,如图4所示。频谱频率范围50-400kHz,分辨率25Hz,每张频谱包含14001个频率变量。本研究选择变量数为700的分段平均频谱建立模型,如图5所示。声信号处理在MATLAB 2019b(美国MathWorks公司)中完成。Acoustic emission signals during the fluidized bed granulation process were collected until the end of granulation. Before modeling, the original time-domain signal collected is converted into a frequency-domain signal. The specific scheme is to divide the 2s time-domain signal into 50 segments, and each segment of the time-domain signal is subjected to a fast Fourier transform (FFT) to obtain a spectrum. Average the 50 spectrums to obtain the average spectrogram of the 2s acoustic signal, as shown in Figure 4. The frequency range of the spectrum is 50-400kHz, the resolution is 25Hz, and each spectrum contains 14001 frequency variables. In this study, a segmented average spectrum with 700 variables was selected to build the model, as shown in Figure 5. Acoustic signal processing was done in MATLAB 2019b (MathWorks, USA).

针对流化床制粒过程中所获得的声发射信号存在的包括采样时间间隔不均匀、数据采集时间点存在偏差的问题,采用相关系数校正法对过程数据进行对齐处理,经过预处理前后的频谱图如图6、7所示。在相关系数校正过程中,待对齐光谱向量的端点固定不动,根据松弛参数将光谱向量分成与参照光谱向量相同的段数,从最后一段开始同参照光谱向量进行比较和校正,在松弛参数前向和后向范围内通过拉伸或压缩变换来调节待对齐的数据片段,从而得到相关系数最大的一组数据向量,依此类推,最终得到一组对齐后的重组信号向量,相关系数的计算公式如下:In view of the problems of uneven sampling time interval and deviation of data collection time points in the acoustic emission signals obtained in the process of fluidized bed granulation, the correlation coefficient correction method is used to align the process data, and the spectrum before and after preprocessing is used to align the process data. Figures are shown in Figures 6 and 7. In the process of correlation coefficient correction, the endpoints of the spectral vectors to be aligned are fixed, and the spectral vectors are divided into the same number of segments as the reference spectral vectors according to the relaxation parameters. The last segment is compared and corrected with the reference spectral vectors. Adjust the data segments to be aligned by stretching or compressing transformation in the backward range, so as to obtain a set of data vectors with the largest correlation coefficient, and so on, and finally obtain a set of aligned recombination signal vectors, the calculation formula of the correlation coefficient as follows:

Figure BDA0002604464010000051
Figure BDA0002604464010000051

将流化床制粒过程中获得的声发射三维数据

Figure BDA0002604464010000052
(I×J×K,I为实验批次,J为信号强度,K为时间),按变量方向进行展开,形成I×K行、J列的二维矩阵X(IK×J);Acoustic emission 3D data obtained during fluidized bed granulation
Figure BDA0002604464010000052
(I×J×K, I is the experimental batch, J is the signal intensity, and K is the time), expand according to the variable direction to form a two-dimensional matrix X (IK×J) with I×K rows and J columns;

使用6个正常操作条件下的养胃颗粒流化床制粒过程的声发射信号建立多变量统计过程监控模型。A multivariate statistical process monitoring model was established using the acoustic emission signals of the fluidized bed granulation process of Yangwei granules under six normal operating conditions.

多变量统计过程监控模型包括主成分控制图、Hotelling's T2控制图和DModX控制图。Multivariate statistical process monitoring models include principal components control charts, Hotelling's T2 control charts, and DModX control charts.

其中,主成分得分轨迹能可直观地表征过程发生的变化,用于制粒过程的监控和预测。主成分得分轨迹计算公式为:Among them, the principal component score trajectory can intuitively characterize the changes in the process, which can be used for monitoring and prediction of the granulation process. The calculation formula of the principal component score trajectory is:

Figure BDA0002604464010000053
Figure BDA0002604464010000053

式中,TNOC为NOC批次的得分矩阵,

Figure BDA0002604464010000054
为NOC批次的载荷矩阵,ENOC为残差矩阵;采用均值±3倍标准偏差为主成分控制模型的主成分控制图的控制限。where T NOC is the score matrix of NOC batches,
Figure BDA0002604464010000054
is the loading matrix of the NOC batch, and E NOC is the residual matrix; the control limits of the principal component control chart of the principal component control model using the mean ± 3 times the standard deviation.

Hotelling's T2统计过程监控模型中,Hotelling's T2统计量为主成分空间内样本到原点的马氏距离,可以通过主成分模型内部的主成分向量的波动来反映变量的变化情况,其计算公式为:In Hotelling's T 2 statistical process monitoring model, Hotelling's T 2 statistic is the Mahalanobis distance from the sample to the origin in the principal component space, which can reflect the change of the variable through the fluctuation of the principal component vector inside the principal component model. The calculation formula is: :

Figure BDA0002604464010000055
Figure BDA0002604464010000055

式中,ti是第i个主成分的得分,

Figure BDA0002604464010000056
为ti的方差,A表示主成分控制模型中主成分的数量;Hotelling's T2的控制限用用F分布来计算,公式为:where t i is the score of the i-th principal component,
Figure BDA0002604464010000056
is the variance of t i , A represents the number of principal components in the principal component control model; the control limit of Hotelling's T 2 is calculated by F distribution, and the formula is:

Figure BDA0002604464010000057
Figure BDA0002604464010000057

式中,K为校正集批次数目,F为置信水平为1-α,自由度为(A,K-A)时F分布的临界值。In the formula, K is the number of batches in the calibration set, F is the critical value of the F distribution when the confidence level is 1-α and the degree of freedom is (A, K-A).

DModX统计过程监控模型中,DModX统计量为残差标准偏差,即观测值到模型的绝对距离,反映模型外部数据变化程度的度量,任一批次在k时刻的DModX值计算公式为:In the DModX statistical process monitoring model, the DModX statistic is the residual standard deviation, that is, the absolute distance from the observed value to the model, which reflects the degree of change in the external data of the model. The calculation formula of the DModX value of any batch at time k is:

Figure BDA0002604464010000058
Figure BDA0002604464010000058

式中,en为观测值xn的残差向量,

Figure BDA0002604464010000059
为所述主成分控制模型中n时刻xn的预测值,K为光谱变量,A表示所述的主成分控制模型中主成分的数量;In the formula, e n is the residual vector of the observation value x n ,
Figure BDA0002604464010000059
is the predicted value of x n at time n in the principal component control model, K is a spectral variable, and A represents the number of principal components in the principal component control model;

Figure BDA0002604464010000061
Figure BDA0002604464010000061

式中

Figure BDA0002604464010000062
为所述校正集的平均值,SD为建立所述的主成分控制模型中样本DModX统计量的标准偏差。in the formula
Figure BDA0002604464010000062
is the mean value of the calibration set, SD is the standard deviation of the sample DModX statistic in establishing the principal component control model.

将校正集数据代入式(2)、式(3)、式(5)计算得到相应的监控指标,建立主成分控制模型、Hotelling's T2控制模型和DModX控制模型。Substitute the calibration set data into Equation (2), Equation (3), and Equation (5) to calculate the corresponding monitoring indicators, and establish the principal component control model, Hotelling's T 2 control model and DModX control model.

将验证集及过程运行状态的监测数据代入式(4)、式(6)计算得到相应的统计量,监测新批次的流化制粒状态。对于新的被检验批次,如果过程轨迹落于所建立多变量统计过程控制图的控制限以内,则认为批次处于正常状态,反之,则认为批次处于异常状态。Substitute the monitoring data of the verification set and the process operating state into equations (4) and (6) to calculate the corresponding statistics, and monitor the fluidized granulation state of the new batch. For a new inspected batch, if the process trajectory falls within the control limits of the established multivariate statistical process control chart, the batch is considered to be in a normal state, otherwise, the batch is considered to be in an abnormal state.

以上详细描述了本发明的较佳具体实施例。应当理解,本领域的普通技术无需创造性劳动就可以根据本发明的构思作出诸多修改和变化。因此,凡本技术领域中技术人员依本发明的构思在现有技术的基础上通过逻辑分析、推理或者有限的实验可以得到的技术方案,皆应在由权利要求书所确定的保护范围内。The preferred embodiments of the present invention have been described in detail above. It should be understood that many modifications and changes can be made according to the concept of the present invention by those skilled in the art without creative efforts. Therefore, all technical solutions that can be obtained by those skilled in the art through logical analysis, reasoning or limited experiments on the basis of the prior art according to the concept of the present invention shall fall within the protection scope determined by the claims.

Claims (10)

1.一种流化床中药颗粒制备过程声发射监控方法,其特征在于,包括步骤:1. a fluidized bed Chinese medicine particle preparation process acoustic emission monitoring method, is characterized in that, comprises the steps: (1)通过设置于流化床床体的声发射传感器采集声信号数据;(1) Acoustic signal data is collected by an acoustic emission sensor arranged on the fluidized bed; (2)将采集到的流化床在正常工作状态下的所述声信号数据作为校正集;通过快速傅里叶变换将所述校正集的所述声信号数据由时域信号转化为频域信号,并将频谱均分为N段,每段计算平均值,得到包含N个变量的分段平均频谱;采用数据对齐算法对频谱数据进行对齐处理;(2) Use the collected acoustic signal data of the fluidized bed in a normal working state as a calibration set; convert the acoustic signal data of the calibration set from a time domain signal to a frequency domain through fast Fourier transform The spectrum is divided into N segments, the average value of each segment is calculated, and the segmented average spectrum containing N variables is obtained; the spectrum data is aligned by the data alignment algorithm; (3)建立包括主成分控制模型、Hotelling's T2控制模型和DModX控制模型的多变量统计过程监控模型;通过包含至少6个批次的正常工作状态下流化床的所述声信号数据的所述校正集对所述主成分控制模型、Hotelling's T2控制模型和DModX控制模型进行训练;(3) establishing a multivariate statistical process monitoring model including a principal component control model, a Hotelling's T2 control model and a DModX control model; by including at least 6 batches of all the acoustic signal data of the fluidized bed under normal working conditions The calibration set is used to train the principal component control model, Hotelling's T2 control model and DModX control model; (4)将训练所得的多变量统计过程监控模型用于对流化床中药颗粒的制备过程进行监控。(4) The multivariate statistical process monitoring model obtained by training is used to monitor the preparation process of TCM granules in the fluidized bed. 2.如权利要求1所述的流化床中药颗粒制备过程声发射监控方法,其中,步骤(1)中,所述的声发射传感器被设置所述的流化床的装料室的取样口高度处。2. The method for monitoring acoustic emission in the preparation process of traditional Chinese medicine particles in a fluidized bed as claimed in claim 1, wherein, in step (1), the acoustic emission sensor is set at the sampling port of the charging chamber of the fluidized bed height. 3.如权利要求2所述的流化床中药颗粒制备过程声发射监控方法,其中,步骤(2)中,采用相关系数校正法对所述频谱数据进行对齐。3 . The method for monitoring acoustic emission in the preparation process of fluidized bed Chinese medicine particles according to claim 2 , wherein, in step (2), a correlation coefficient correction method is used to align the spectral data. 4 . 4.如权利要求3所述的流化床中药颗粒制备过程声发射监控方法,其中,步骤(3)中,所述主成分控制模型的主成分得分轨迹计算公式为:4. The method for monitoring acoustic emission in the preparation process of fluidized bed Chinese medicine granules as claimed in claim 3, wherein, in step (3), the calculation formula of the principal component score trajectory of the principal component control model is:
Figure FDA0002604464000000011
Figure FDA0002604464000000011
式中,TNOC为NOC批次的得分矩阵,
Figure FDA0002604464000000012
为NOC批次的载荷矩阵,ENOC为残差矩阵;
where T NOC is the score matrix of NOC batches,
Figure FDA0002604464000000012
is the loading matrix of the NOC batch, and E NOC is the residual matrix;
采用均值±3倍标准偏差为所述主成分控制模型的主成分控制图的控制限。The mean ± 3 times the standard deviation was used as the control limit of the principal component control chart of the principal component control model.
5.如权利要求4所述的流化床中药颗粒制备过程声发射监控方法,其中,步骤(3)中,所述的Hotelling's T2控制模型的计算公式为:5. The method for monitoring acoustic emission in the preparation process of fluidized bed Chinese medicine particles as claimed in claim 4, wherein, in step (3), the calculation formula of described Hotelling's T 2 control model is:
Figure FDA0002604464000000013
Figure FDA0002604464000000013
式中,ti是第i个主成分的得分,
Figure FDA0002604464000000014
为ti的方差,A表示所述的主成分控制模型中主成分的数量;Hotelling's T2的控制限用用F分布来计算,公式为:
where t i is the score of the i-th principal component,
Figure FDA0002604464000000014
is the variance of t i , A represents the number of principal components in the described principal component control model; the control limit of Hotelling's T 2 is calculated with F distribution, and the formula is:
Figure FDA0002604464000000015
Figure FDA0002604464000000015
式中,K为所述校正集的批次数目,F为置信水平为1-α,自由度为(A,K-A)时F分布的临界值。In the formula, K is the batch number of the calibration set, F is the critical value of the F distribution when the confidence level is 1-α and the degree of freedom is (A, K-A).
6.如权利要求4所述的流化床中药颗粒制备过程声发射监控方法,其中,步骤(3)中,所述的DModX控制模型中任一批次的声信号数据在k时刻的DModX值计算公式为:6. The method for monitoring acoustic emission of fluidized bed Chinese medicine particle preparation process as claimed in claim 4, wherein, in step (3), the DModX value of the acoustic signal data of any batch in the described DModX control model at time k The calculation formula is:
Figure FDA0002604464000000021
Figure FDA0002604464000000021
式中,en为观测值xn的残差向量,
Figure FDA0002604464000000022
为所述主成分控制模型中n时刻xn的预测值,K为光谱变量,A表示所述的主成分控制模型中主成分的数量;
In the formula, e n is the residual vector of the observation value x n ,
Figure FDA0002604464000000022
is the predicted value of x n at time n in the principal component control model, K is a spectral variable, and A represents the number of principal components in the principal component control model;
通过均值±3倍标准偏差确立所述DModX控制模型的控制限,公式为:The control limits of the DModX control model were established by the mean ± 3 times the standard deviation, and the formula was:
Figure FDA0002604464000000023
Figure FDA0002604464000000023
式中,
Figure FDA0002604464000000024
为所述校正集的平均值,SD为建立所述的主成分控制模型中样本DModX统计量的标准偏差。
In the formula,
Figure FDA0002604464000000024
is the mean value of the calibration set, SD is the standard deviation of the sample DModX statistic in establishing the principal component control model.
7.一种流化床制备中药颗粒的声发射监控系统,其特征在于,包括7. an acoustic emission monitoring system for preparing traditional Chinese medicine particles in a fluidized bed, is characterized in that, comprising 设置于流化床床体的声发射传感器,用于接收流化床的声信号数据;The acoustic emission sensor arranged on the fluidized bed body is used to receive the acoustic signal data of the fluidized bed; 放大器和采集卡,用于放大和固定时间间隔采集所述的声信号数据;Amplifier and acquisition card for amplifying and acquiring the acoustic signal data at fixed time intervals; 计算机系统,所述的计算机系统包括数据预处理程序模块和多变量统计过程监控程序模块,其中所述的数据预处理程序模块通过快速傅里叶变换将所述声信号数据由时域信号转化为频域信号,并将频谱均分为N段,每段计算平均值,得到包含N个变量的分段平均频谱;采用数据对齐算法对频谱数据进行对齐处理;A computer system, the computer system includes a data preprocessing program module and a multivariate statistical process monitoring program module, wherein the data preprocessing program module converts the acoustic signal data from a time domain signal to a fast Fourier transform. frequency domain signal, and divide the spectrum into N segments, and calculate the average value of each segment to obtain a segmented average spectrum containing N variables; use the data alignment algorithm to align the spectrum data; 所述的多变量统计过程监控程序模块包括主成分控制模块、Hotelling's T2控制模块和DModX控制模块。The multivariable statistical process monitoring program module includes a principal component control module, a Hotelling's T2 control module and a DModX control module. 8.如权利要求7所述的流化床制备中药颗粒的声发射监控系统,其中,所述主成分控制模块中的主成分得分轨迹计算公式为:8. The acoustic emission monitoring system for preparing traditional Chinese medicine particles in a fluidized bed as claimed in claim 7, wherein the calculation formula of the principal component score trajectory in the principal component control module is:
Figure FDA0002604464000000025
Figure FDA0002604464000000025
式中,TNOC为NOC批次的得分矩阵,
Figure FDA0002604464000000026
为NOC批次的载荷矩阵,ENOC为残差矩阵;
where T NOC is the score matrix of NOC batches,
Figure FDA0002604464000000026
is the loading matrix of the NOC batch, and E NOC is the residual matrix;
采用均值±3倍标准偏差为所述主成分控制模型的主成分控制图的控制限。The mean ± 3 times the standard deviation was used as the control limit of the principal component control chart of the principal component control model.
9.如权利要求7所述的流化床制备中药颗粒的声发射监控系统,其中,所述的Hotelling's T2控制模块的计算公式为:9. the acoustic emission monitoring system of fluidized bed preparation Chinese medicine granules as claimed in claim 7, wherein, the calculation formula of described Hotelling's T 2 control module is:
Figure FDA0002604464000000027
Figure FDA0002604464000000027
式中,ti是第i个主成分的得分,
Figure FDA0002604464000000028
为ti的方差,A表示所述的主成分控制模型中主成分的数量;Hotelling's T2的控制限用用F分布来计算,公式为:
where t i is the score of the i-th principal component,
Figure FDA0002604464000000028
is the variance of t i , A represents the number of principal components in the described principal component control model; the control limit of Hotelling's T 2 is calculated with F distribution, and the formula is:
Figure FDA0002604464000000029
Figure FDA0002604464000000029
式中,K为所述校正集的批次数目,F为置信水平为1-α,自由度为(A,K-A)时F分布的临界值。In the formula, K is the batch number of the calibration set, F is the critical value of the F distribution when the confidence level is 1-α and the degree of freedom is (A, K-A).
10.如权利要求7所述的流化床制备中药颗粒的声发射监控系统,其中,所述的DModX控制模块中任一批次的声信号数据在k时刻的DModX值计算公式为:10. The acoustic emission monitoring system of fluidized bed preparation of traditional Chinese medicine particles as claimed in claim 7, wherein, the DModX value calculation formula of the acoustic signal data of any batch in the described DModX control module at time k is:
Figure FDA0002604464000000031
Figure FDA0002604464000000031
式中,en为观测值xn的残差向量,
Figure FDA0002604464000000032
为所述主成分控制模型中n时刻xn的预测值,K为光谱变量,A表示所述的主成分控制模型中主成分的数量;
In the formula, e n is the residual vector of the observation value x n ,
Figure FDA0002604464000000032
is the predicted value of x n at time n in the principal component control model, K is a spectral variable, and A represents the number of principal components in the principal component control model;
通过均值±3倍标准偏差确立所述DModX控制模型的控制限,公式为:The control limits of the DModX control model were established by the mean ± 3 times the standard deviation, and the formula was:
Figure FDA0002604464000000033
Figure FDA0002604464000000033
式中,
Figure FDA0002604464000000034
为所述校正集的平均值,SD为建立所述的主成分控制模型中样本DModX统计量的标准偏差。
In the formula,
Figure FDA0002604464000000034
is the mean value of the calibration set, SD is the standard deviation of the sample DModX statistic in establishing the principal component control model.
CN202010734810.5A 2020-07-27 2020-07-27 Method and system for monitoring acoustic emission in preparation process of traditional Chinese medicine particles in fluidized bed Pending CN111897298A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010734810.5A CN111897298A (en) 2020-07-27 2020-07-27 Method and system for monitoring acoustic emission in preparation process of traditional Chinese medicine particles in fluidized bed

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010734810.5A CN111897298A (en) 2020-07-27 2020-07-27 Method and system for monitoring acoustic emission in preparation process of traditional Chinese medicine particles in fluidized bed

Publications (1)

Publication Number Publication Date
CN111897298A true CN111897298A (en) 2020-11-06

Family

ID=73189321

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010734810.5A Pending CN111897298A (en) 2020-07-27 2020-07-27 Method and system for monitoring acoustic emission in preparation process of traditional Chinese medicine particles in fluidized bed

Country Status (1)

Country Link
CN (1) CN111897298A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113608431A (en) * 2021-08-06 2021-11-05 山东大学 Dynamic control method for moisture in fluidized bed granulation process and application
CN118297231A (en) * 2024-04-22 2024-07-05 浙江寿仙谷植物药研究院有限公司 Plant medicine fluid bed granulation process optimization method based on correlation analysis

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1375284A (en) * 2001-03-21 2002-10-23 武汉莱奇尔中药现代化研究开发有限公司 Micron level Chinese medicine tablet and its prepn
CN101673096A (en) * 2009-10-26 2010-03-17 浙江大学 Soft-measuring method for density in concentration process of salvia miltiorrhiza injection production
CN101907551A (en) * 2010-07-23 2010-12-08 浙江大学 Ultrasonic detection device and application of density of traditional Chinese medicine extraction concentrate
CN102192955A (en) * 2010-03-03 2011-09-21 中国石油化工股份有限公司 Detection method of solid particle coking amount in reactor
CN111189798A (en) * 2019-12-26 2020-05-22 浙江大学 A process monitoring method for preparing traditional Chinese medicine granules in a fluidized bed based on near-infrared spectroscopy

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1375284A (en) * 2001-03-21 2002-10-23 武汉莱奇尔中药现代化研究开发有限公司 Micron level Chinese medicine tablet and its prepn
CN101673096A (en) * 2009-10-26 2010-03-17 浙江大学 Soft-measuring method for density in concentration process of salvia miltiorrhiza injection production
CN102192955A (en) * 2010-03-03 2011-09-21 中国石油化工股份有限公司 Detection method of solid particle coking amount in reactor
CN101907551A (en) * 2010-07-23 2010-12-08 浙江大学 Ultrasonic detection device and application of density of traditional Chinese medicine extraction concentrate
CN111189798A (en) * 2019-12-26 2020-05-22 浙江大学 A process monitoring method for preparing traditional Chinese medicine granules in a fluidized bed based on near-infrared spectroscopy

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
侯琳熙: "声波测量和流化床聚合反应器多尺度结构的研究", 《中国优秀博硕士学位论文全文数据库(博士) 工程科技I辑》 *
刘景睿: "声发射技术在流化床反应器过程参数检测中的应用", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 *
李宇龙: "模式识别在反应器内颗粒粒径声波法检测中的应用研究", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 *
涂亚庆等: "《复杂信号频率估计方法及应用》", 31 August 2016, 国防工业出版社 *
董叶伟: "基于信息融合的气相PE反应器结块监测", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113608431A (en) * 2021-08-06 2021-11-05 山东大学 Dynamic control method for moisture in fluidized bed granulation process and application
CN113608431B (en) * 2021-08-06 2024-02-02 山东大学 Dynamic control method and application of water in fluidized bed granulation process
CN118297231A (en) * 2024-04-22 2024-07-05 浙江寿仙谷植物药研究院有限公司 Plant medicine fluid bed granulation process optimization method based on correlation analysis

Similar Documents

Publication Publication Date Title
CN111905649A (en) Fluidized bed granulation process state monitoring system and method
CN101961360B (en) Near infrared spectrum identification method for pseudo-ginseng
CN111897298A (en) Method and system for monitoring acoustic emission in preparation process of traditional Chinese medicine particles in fluidized bed
CN114732391B (en) Heart rate monitoring method, device and system in sleep state based on microwave radar
CN103610447B (en) An online detection method of mental load based on forehead EEG signal
CN103808688B (en) Rapid and non-destructive detection of quality consistency of finished pharmaceuticals by near-infrared spectroscopy
CN108420406A (en) Method based on pulse wave sleep stage
CN118151620B (en) An intelligent storage monitoring system suitable for fruit wine fermentation production
CN110245460A (en) A kind of batch process fault monitoring method based on multistage OICA
CN118680581A (en) An intelligent EEG analysis system for assisting the diagnosis of neurological diseases
CN104720788A (en) Evaluation system and method for vital sign monitoring device
WO2022077893A1 (en) Sustained attention regulation system for joint electroencephalogram and finger pressure feedback
CN120260779A (en) A health management system for pediatric asthma patients combined with multi-level supervision
CN107356552A (en) A kind of course monitoring method of alcohol precipitation process of the Radix Astragali based on near-infrared spectrum technique
CN118383720A (en) Biological sleep-wake stage method and system based on brain electromyographic signals
CN120837796B (en) A method for controlling laryngeal mask ventilation in outpatient anesthesia
CN114795168B (en) Method and system for calculating heart rate of vital sign parameter
CN120241095B (en) A screening method for paroxysmal atrial fibrillation based on heart rate variability characteristics
CN119108105B (en) Intelligent prediction system and method for gestational diabetes
CN119626360B (en) Podophyllotoxin extraction process monitoring system based on data analysis
CN105867129A (en) Optimization method of traditional Chinese medicine extraction process based on data mining technology
Thankachan et al. Optimization of real-time analysis of sleep-wake cycle in mice
CN115265665A (en) Intelligent controllable fishery system convenient for real-time monitoring
CN118845038A (en) Auxiliary detection system, device and method for infantile epileptic spasm syndrome
CN117760193A (en) A method and device for judging the end point of fluidized bed drying

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20201106